How a Dutch AI Startup Just Secured Funding to Transform Hearing Care

Jan de Vries · 2026-08-28

Here's an interesting story from across the pond. A small startup in the Netherlands just landed some serious backing to tackle a massive, global health challenge. It's a classic case of a simple idea meeting a huge need. And honestly, the approach is pretty clever. Clementine, based in Maastricht, recently closed a $2 million Seed funding round. This isn't just another tech funding story. It's about applying AI to a sector that's been surprisingly slow to change—hearing healthcare. ### The Backing Behind the Idea The round was led by Healthy.Capital, an Amsterdam-based early-stage investor focused on HealthTech. They've got a sharp eye for promising ventures, having previously backed companies like Pharmi and OpenUp. Their managing partner, Douwe Jippes, put it well. He said Clementine's blend of deep industry knowledge and a scalable AI platform has the potential to fundamentally change how people with hearing loss access care. That's the kind of impact investors love to get behind. Founded just this year by CEO Vince van de Weijer, Clementine (or ClementineAI) calls itself the world's first AI hearing activation platform built for this specific industry. Their goal is straightforward: help hearing clinics turn interested leads into actual patients. In a world where clinics are overwhelmed, that's a game-changer. ### Meet Matthew, The AI Agent Changing the Conversation The core of their platform is an AI agent named Matthew. Think of him as a tireless, empathetic, and infinitely patient hearing care specialist available 24/7. His job is to engage directly with people who might be considering hearing help. Here's what Matthew does that's so different: - Answers questions anytime, without judgment or a waiting list - Educates users about hearing loss and their options - Helps people overcome the emotional and practical hurdles that often stop them from seeking care - Gently guides them toward booking an appointment with a real clinic For the clinics, this means less administrative burden on staff and more qualified appointments. For patients, it means a smoother, less intimidating path to better hearing. As Vince van de Weijer points out, clinics don't necessarily need more leads—they need better, more timely conversations. Matthew ensures no patient inquiry ever goes unanswered. ### The Massive Problem They're Solving Let's talk about scale for a second. The numbers around hearing loss are staggering. - It affects an estimated 1.5 billion people worldwide. - Nearly 80% of those people never seek treatment. - Those who do seek help typically wait over eight years from when they first notice a problem. That's a huge gap between need and action. Clementine's strategy is to use AI combined with behavioral science to meet people where they are. They provide a judgment-free, always-available starting point for engaging with hearing care, long before someone is ready to walk into a clinic. It's about removing barriers, one conversation at a time. ### What's Next for Clementine? This funding comes at a pivotal moment. The company recently expanded its reach through a partnership with Zoolstra, a marketing agency that works with hearing clinics across the United States and Canada. That North American foothold is a big deal. The new capital will be used to deepen the AI's capabilities and forge more partnerships. They're looking beyond just hearing clinics to optical retailers and other healthcare organizations. The vision is to weave this accessible, first-point-of-contact layer into the broader healthcare ecosystem. It's a fascinating example of European innovation addressing a universal human need with technology that feels surprisingly human. By focusing on the conversation first, Clementine might just help millions of people hear the world a little more clearly.